3811. Tysabri-H-C-PSUSA-00002127-202008 3812. Xtandi-H-C-PSUSA-00010095-202008 3813. Lemtrada-H-C-PSUSA-00010055-202009 3814. Rebetol-H-C-PSUSA-00010007-202007 3815. Trulicity-H-C-PSUSA-10311-202009 3816. Angiotensin-II-receptor antagonists (sartans) : Scientific conclusions - Impact of the Article 5(3) scientific opinion on nitrosamines 3817. Isentress-H-C-PSUSA-00010373-202009: EPAR : Scientific conclusions and grounds for the variation to the terms of the marketing authorisation(s) 3818. Xarelto-H-C-PSUSA-00002653-202009 3819. Mysimba-H-C-PSUSA-00010366-202009: EPAR - Scientific conclusions and grounds for the variation to the terms of the marketing authorisation 3820. Keytruda-H-C-PSUSA-00010403-202009 3821. Evoltra-H-C-PSUSA-00000805-201912 3822. Ivozall-H-C-PSUSA-00000805-201912 3823. Lenalidomide Accord-H-C-PSUSA-00001838-201912 3824. Lynparza-H-C-PSUSA-00010322-201912 3825. Thalidomide Celgene-H-C-PSUSA-00002919-201910: EPAR - Scientific conclusions and grounds for the variation to the terms of the marketing authorisation 3826. Revlimid-H-C-PSUSA-00001838-201912 3827. Eylea-H-C-PSUSA-00010020-201911 3828. Skilarence-H-C-PSUSA-00010647-202006 3829. Pregabalin Pfizer-H-C-PSUSA-00002511-202001: EPAR - Scientific conclusions and grounds for the variation to the terms of the marketing authorisation 3830. Tivicay-H-C-PSUSA-00010075-202001 3831. Sivextro-H-C-PSUSA-00010369-202006 3832. Incresync-H-C-PSUSA-00010061-202004 3833. Vipidia-H-C-2182-PSUSA-00010061-202004: EPAR - Scientific conclusions and grounds recommending the variation to the terms of the marketing authorisation 3834. Inbrija-H-C-PSUSA-00107800-202006 3835. Doptelet-H-C-PSUSA-00010779-202005 3836. Effentora-H-C-PSUSA-00001369-202004 3837. PecFent-H-C-PSUSA-00001369-202004: EPAR - Scientific conclusions and grounds recommending the variation to the terms of the marketing authorisation 3838. Instanyl-H-C-PSUSA-00001369-202004 3839. Ozempic-H-C-PSUSA-00010671-202005 3840. Blincyto-H-C-PSUSA-00010460-202006: EPAR - Scientific conclusions and grounds for the variation to the terms of the marketing authorisation